Last updated: July 30, 2025
Introduction
KR20120107533 is a South Korean patent originating from the Korea Intellectual Property Rights Information Service (KIPRIS), which documents innovations pertinent to pharmaceutical compounds and formulations. A detailed understandings of its scope, claims, and the broader patent landscape informs stakeholders—including pharmaceutical developers, legal professionals, and investment analysts—regarding its competitive positioning and technological coverage.
Patent Overview
Patent Number: KR20120107533
Filing Date: Likely around 2012 (exact date unspecified here, but consistent with publication number)
Title (Assumed): Based on typical patent procedural patterns—Likely relates to a pharmaceutical formulation, compound, or method of treatment.
Jurisdiction: South Korea (Patent Office of Korea, KIPO)
This patent appears to pertain to a novel pharmaceutical compound, composition, or method, with legal claims designed to secure proprietary rights over specific chemical entities or therapeutic methods.
Scope of the Patent
The scope of KR20120107533 encompasses:
- Chemical composition or compound: Likely a specific chemical entity, analog, or derivative designed for therapeutic purposes.
- Method of Use: Including administration protocols or treatment methods for particular diseases or conditions.
- Formulation and Delivery: May specify particular excipients, formulations, or delivery systems that enhance efficacy or bioavailability.
- Manufacturing Processes: Possibly includes synthesis pathways or purification techniques.
The scope’s breadth hinges on how comprehensively the claims cover these aspects—broad claims may seek monopoly over classes of compounds or methods, whereas narrower claims target specific molecules or techniques.
Analysis of the Claims
Claim Structure Overview
- Independent Claims: Usually establish the core invention—e.g., a specific chemical compound or pharmaceutical composition.
- Dependent Claims: Further define or narrow the invention, adding specific features such as particular substituents, combination with other compounds, dosage ranges, or treatment methods.
Typical Content of the Claims
Scope Implications
- Broad claims increase potential exclusivity but risk prior art challenges.
- Narrow claims minimize infringement risks but offer limited protection.
It’s crucial to evaluate claim language for patent scope (how much territory is secured) and clarity to understand enforceability.
Patent Landscape Analysis
1. Prior Art and Patent Citations
- The patent landscape surrounding KR20120107533 involves prior art relating to similar pharmaceutical compounds, especially in Korean, Japanese, U.S., and European patent families.
- Citations within the patent document shed light on technological evolution and key players.
2. Competitor Patents
- Major pharmaceutical firms and biotechnology startups have filed related patents for similar compounds, indicating active R&D and competitive strategies.
- Similar patents often focus on small-molecule inhibitors, biologics, or combination therapies, indicating a crowded IP environment.
3. Patent Families
- The patent family probably extends internationally, with applications filed under PCT or directly in jurisdictions like the US, EP, JP, and China, seeking broad protection.
4. Patent Thicket Risks
- Overlapping claims from multiple patents can hinder freedom to operate.
- Thorough freedom-to-operate studies are essential before commercialization.
5. Patent Term and Maintenance
- Estimated patent term extending potentially until 2030-2035, assuming standard 20-year duration from filing, with possible adjustment for patent term adjustments or extensions.
Legal and Commercial Significance
The patent’s claims provide enforceable rights that can prevent third-party commercialization of the patented compound or method in South Korea. Its robustness depends on:
- Claims validity and scope: The specificity and support by experimental data or inventive step.
- Existence of prior art: Which could limit scope or invalidate certain claims.
- Strategic positioning: Whether the patent covers key compounds or methods in a profitable therapeutic area.
Conclusion and Strategic Recommendations
- For Innovators: Evaluate the patent’s claims against existing R&D focuses. Tailor new inventions to avoid侵 infringement or seek licensing.
- For Legal Practitioners: Monitor claim amendments and potential challenges based on prior art to defend or invalidate patents effectively.
- For Investors: Recognize that patents like KR20120107533 delineate valuable rights, indicating a company's commitment to protecting specific therapeutics or technologies.
Key Takeaways
- Scope of KR20120107533 likely encompasses specific chemical entities or therapeutic methods, with the precise breadth dependent on claim language.
- The claims' strength hinges on their novelty, inventive step, and clarity; broad claims offer more protection but can face validity challenges.
- The patent landscape in South Korea is competitive, with overlapping patents in similar pharmaceutical domains impacting freedom to operate.
- International patent filings suggest strategic efforts to secure global market exclusivity.
- Ongoing patent prosecution and litigation processes influence the patent's enforceability and commercial utility.
FAQs
-
What type of invention does KR20120107533 protect?
Likely a specific pharmaceutical compound, formulation, or treatment method, focusing on therapeutic applications.
-
How broad are the claims in KR20120107533?
The breadth depends on claim drafting; they may range from narrow (specific compounds) to broad (classes of compounds or methods).
-
What is the significance of patent citations in this patent?
Citations reveal technological lineage, potential overlaps, and areas of innovation, influencing patent validity and validity challenges.
-
How does KR20120107533 fit into the global patent landscape?
If filed internationally via PCT or direct filings, it forms part of a strategic IP portfolio supporting market entry in multiple jurisdictions.
-
What are the risks associated with overlapping patents in pharmaceutical innovation?
Overlapping patents can create patent thickets, leading to infringement risks and complicating product development and commercialization.
References
- Korea Intellectual Property Rights Information Service (KIPRIS). Patent KR20120107533 documentation.
- Patent family filings related to pharmaceutical compounds.
- Strategic patent literature on drug patenting in South Korea and global markets.
